Document Detail


Fulminant myocarditis successfully treated with high-dose immunoglobulin.
MedLine Citation:
PMID:  15301907     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fulminant myocarditis is characterized by the rapid development of life-threatening congestive heart failure. Intravenous immunoglobulin (IVIG), by modulating the immune response, may be used for the treatment of acute myocarditis. We report two children with fulminant myocarditis successfully treated with a 10-h infusion of high-dose IVIG. In those cases, a dramatic clinical improvement was achieved, with both cardiac enzymes and myocardial function normalized within 1-2 weeks after treatment.
Authors:
Hae Soon Kim; Sejung Sohn; Ji Yun Park; Jeong Wan Seo
Related Documents :
3461737 - Accelerated bone formation causing profound hypocalcemia in acute leukemia.
12381097 - Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of se...
20025587 - Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magneti...
19098207 - Acute myocarditis: noninvasive evaluation with cardiac mri and transthoracic echocardio...
2520017 - Bioprosthetic versus mechanical valve replacement in patients with infective endocarditis.
25195357 - Surgical treatment of left ventricular pseudoaneurysm.
Publication Detail:
Type:  Case Reports; Letter    
Journal Detail:
Title:  International journal of cardiology     Volume:  96     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-08-10     Completed Date:  2004-12-23     Revised Date:  2006-07-12    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  485-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Child
Dose-Response Relationship, Drug
Female
Humans
Immunoglobulins, Intravenous / administration & dosage*
Myocarditis / drug therapy*
Chemical
Reg. No./Substance:
0/Immunoglobulins, Intravenous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sydenham's chorea-clinical characteristics of nine patients.
Next Document:  Fistulous connection between internal mammary graft and pulmonary vasculature after coronary artery ...